Acurx Pharmaceuticals Inc. (NASDAQ: ACXP)
$0.7197
+0.0207 ( +2.81% ) 155.3K
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Market Data
Open
$0.7197
Previous close
$0.6990
Volume
155.3K
Market cap
$14.03M
Day range
$0.6810 - $0.7350
52 week range
$0.6800 - $4.5300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 15, 2024 |
| 10-q | Quarterly Reports | 52 | May 14, 2024 |
| defa14a | Other | 3 | Apr 29, 2024 |
| def | Proxies and info statements | 4 | Apr 29, 2024 |
| ars | Annual reports | 1 | Apr 29, 2024 |
| rw | Other | 1 | Apr 17, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| fwp | Other | 24 | Apr 02, 2024 |